DOCSLIB.ORG

Disrupting Polyamine Homeostasis As a Therapeutic Strategy for Neuroblastoma Nicholas F

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Disrupting Polyamine Homeostasis As a Therapeutic Strategy for Neuroblastoma Nicholas F Published OnlineFirst September 29, 2009; DOI: 10.1158/1078-0432.CCR-08-3213 Molecular Pathways Disrupting Polyamine Homeostasis as a Therapeutic Strategy for Neuroblastoma Nicholas F. Evageliou and Michael D. Hogarty Abstract MYC genes are deregulated in a plurality of human cancers. Through direct and indirect mechanisms, the MYC network regulates the expression of >15% of the human genome, including both protein-coding and noncoding RNAs. This complexity has complicated efforts to define the principal pathways mediating MYC's oncogenic activ- ity. MYC plays a central role in providing for the bioenergetic and biomass needs of proliferating cells, and polyamines are essential cell constituents supporting many of these functions. The rate-limiting enzyme in polyamine biosynthesis, ODC, is a bona fide MYC target, as are other regulatory enzymes in this pathway. A wealth of data link enhanced polyamine biosynthesis to cancer progression, and polyamine depletion may limit the malignant transformation of preneoplastic lesions. Studies with transgen- ic cancer models also support the finding that the effect of MYC on tumor initiation and progression can be attenuated through the repression of polyamine production. High- risk neuroblastomas (an often lethal embryonal tumor in which MYC activation is paramount) deregulate numerous polyamine enzymes to promote the expansion of intracellular polyamine pools. Selective inhibition of key enzymes in this pathway, e.g., using DFMO and/or SAM486, reduces tumorigenesis and synergizes with chemotherapy to regress tumors in preclinical models. Here, we review the potential clinical application of these and additional polyamine depletion agents to neuroblastoma and other advanced cancers in which MYC is operative. (Clin Cancer Res 2009;15(19):5956–61) Background in neural stem cells, for example, leads to an aberrant nuclear structure mimicking a heterochromatin state accompanied by The MYC proto-oncogenes, which include MYC, MYCN, and widespread histone modifications (5). Such higher-order regu- MYCL, are among the most frequently deregulated genes in latory activities may explain MYC's profound influence on tran- cancer. The MYC proto-oncogenes encode highly homolo- scription and the diversity in putative target genes identified gous basic-helix-loop-helix leucine zipper transcription factors across different model systems. that are biologically redundant, but differentially expressed spa- MYC activity is tightly regulated through transcriptional and tiotemporally. MYC genes function through heterodimerization posttranslational mechanisms, with rapid degradation of Myc with Max and operate within a network of related proteins to protein in concert with cell cycle exit. In many cancers, MYC regulate transcription through interactions at E-box sequences genes are deregulated through genomic translocation or ampli- within promoters of diverse target genes (1). Many estimates fication events that lead to supraphysiologic Myc expression. have the MYC network governing the expression of > 15% of Although mutations in Myc have been identified in Burkitt's all human genes (2, 3) and a growing roster of noncoding RNAs lymphoma cells (accompanying rather than replacing activating (4). A simplified gene-specific model of transcriptional regula- translocations; ref. 6), Myc oncogenesis typically results from tion has been expanded with the appreciation that MYC genes deregulated overexpression of wild-type protein. Such large- also contribute to global chromatin regulation. Loss of MYCN scale biological reprogramming of cells through enforced expression of this promiscuous transactivator and chromatin regulator is highly oncogenic, and the ubiquity of MYC activa- Authors' Affiliations: Division of Oncology, The Children's Hospital of tion across tumor types makes it an attractive cancer target. Philadelphia and Department of Pediatrics, University of Pennsylvania Inhibiting grossly deregulated transcription factors remains a School of Medicine, Philadelphia, Pennsylvania daunting therapeutic challenge, yet pharmaceutical successes Received 5/4/09; revised 6/3/09; accepted 6/3/09; published OnlineFirst 9/29/09. continue to whittle away at the list of domains considered “un- Grant support: The author's laboratory is supported by National Institutes druggable”; thus, direct Myc antagonism may be an achievable of Health CA97323 and the Richard and Sheila Sanford Chair in Pediatric Oncology (M.D. Hogarty), and by the Children's Neuroblastoma Cancer goal. However, a secondary concern for such an approach is Foundation (N.F. Evageliou). that systemic interference with Myc might be quite toxic, as Requests for reprints: Michael D. Hogarty, Division of Oncology, The Chil- it is indispensable for cell cycle entry in response to mitogenic dren's Hospital of Philadelphia, 9 North ARC, Suite 902C, 3615 Civic Center signals. This fear has been partially allayed by evidence that a Boulevard, Philadelphia, PA 19104-4318. Phone: 215-590-3931; Fax: 215- 590-3770; E-mail: [email protected]. profound dominant-negative Myc contruct can be activated F 2009 American Association for Cancer Research. globally in mice without undue toxicity (7). An alternative ap- doi:10.1158/1078-0432.CCR-08-3213 proach to interfering directly with Myc is to define the critical Clin Cancer Res 2009;15(19) October 1, 20095956 www.aacrjournals.org Downloaded from clincancerres.aacrjournals.org on October 1, 2021. © 2009 American Association for Cancer Research. Published OnlineFirst September 29, 2009; DOI: 10.1158/1078-0432.CCR-08-3213 Polyamine Depletion in Neuroblastoma downstream pathways necessary for its oncogenic activity. (OAZ1, OAZ2, OAZ3) are themselves responsive to intracellular Among these may be more immediately tractable drug targets polyamines to provide a negative feedback loop (20). Further- that exploit cancer-specific aspects of Myc activity with a greater more, two mammalian antizyme inhibitors have been identi- therapeutic index. fied [AZIN1 (ref. 21) and, more recently, ADC (ref. 22)] that An improved understanding of Myc biology has emerged encode enzymatically inactive Odc homologs that compete to from high-dimensional assays that provide global transcrip- neutralize the antizymes and therefore constitute a positive reg- tome and/or Myc-chromatin binding site data. These platforms ulator of Odc activity (23). This level of control underscores the have generated daunting lists of genes and chromatin binding importance of modulating Odc activity to ensure cellular fitness. sites that underscore the widespread involvement of Myc in Polyamine catabolism occurs via the acetylation of spermi- diverse biological processes. Still, patterns are discernible with- dine or spermine by the readily inducible spermidine/ in this complexity. The most conserved set of MYC target genes spermine-N-acetyltransferase, SAT1 (24). Acetylated polyamines functions in ribosomal biogenesis and protein metabolism may be exported from the cell through specific transmembrane and processing, and this is true for both MYC (3) and MYCN solute carriers to reduce intracellular levels (25). Alternatively, (8). Additionally, programs that direct carbon assimilation, an- acetylated spermine and spermidine may be converted through abolic pathways, and bioenergetics are all targeted by Myc (3). PAOX oxidase activity to spermidine and putrescine, respective- Thus, Myc orchestrates a program redirecting metabolism to ly, whereas SMOX oxidase activity can convert spermine to sper- provide for the energetic needs of the cell through augmented midine directly. These conversions allow for homeostatic aerobic glycolysis (9) and glutaminolysis (10), as well as the control over the repertoire of natural polyamines, which may biomass needs through enhanced synthesis and processing of be important for maintaining functions unique to select polya- RNA, DNA, protein, lipid, and polyamine precursors. mines [such as protein translation, in which spermidine acts as a Polyamines are multifunctional polycations found in nearly all gate-keeper by regulating the activity of eIF5A (ref. 26); Fig. 2]. living organisms. Polyamines support biological processes Finally, an as yet uncharacterized energy-dependent polyamine through the stabilization of anionic macromolecules and mod- transporter functions to selectively import polyamines present ulate DNA:protein and protein:protein interactions. A detailed in the microenvironment through dietary intake, export from understanding of polyamine activities is hampered by the fact neighboring cells, or synthesis by intestinal flora. This pathway that they participate in mainly transient ionic interactions that can restore polyamine levels under conditions of biosynthetic are difficult to study. Still, polyamine homeostasis is essential blockade and may potentially undermine therapeutic efforts for cell survival, and depletion activates cellular checkpoints to diminish intracellular polyamines. that constrain proliferation or induce apoptosis (11). Reduced This multitude of regulatory controls highlights the critical polyamines are seen in postmitotic and senescent cells, whereas need for polyamine homeostasis, and as polyamines operate enhanced polyamine biosynthesis accompanies normal as well downstream of Myc to support proliferation, they provide an as oncogenic proliferation (12, 13). That polyamine biosynthe- intriguing cancer target. Indeed, substantial effort has been sis may be instructive in the cancer process, rather
Load more

Recommended publications
  • A Minimal Set of Internal Control Genes for Gene Expression Studies in Head
    bioRxiv preprint doi: https://doi.org/10.1101/108381; this version posted February 14, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 A minimal set of internal control genes for gene expression studies in head 2 and neck squamous cell carcinoma. 1 1 1 2 3 Vinayak Palve , Manisha Pareek , Neeraja M Krishnan , Gangotri Siddappa , 2 2 1,3* 4 Amritha Suresh , Moni Abraham Kuriakose and Binay Panda 5 1 6 Ganit Labs, Bio-IT Centre, Institute of Bioinformatics and Applied Biotechnology, 7 Bangalore 560100 2 8 Mazumdar Shaw Cancer Centre and Mazumdar Shaw Centre for Translational 9 Research, Bangalore 560096 3 10 Strand Life Sciences, Bangalore 560024 11 * Corresponding author: [email protected] 12 13 Abstract: 14 Background: Selection of the right reference gene(s) is crucial in the analysis and 15 interpretation of gene expression data. In head and neck cancer, studies evaluating 16 the efficacy of internal reference genes are rare. Here, we present data for a minimal 17 set of candidates as internal control genes for gene expression studies in head and 18 neck cancer. 19 Methods: We analyzed data from multiple sources (in house whole-genome gene 20 expression microarrays, n=21; TCGA RNA-seq, n=42, and published gene 21 expression studies in head and neck tumors from literature) to come up with a set of 22 genes (discovery set) for their stable expression across tumor and normal tissues.
    [Show full text]
  • Aneuploidy: Using Genetic Instability to Preserve a Haploid Genome?
    Health Science Campus FINAL APPROVAL OF DISSERTATION Doctor of Philosophy in Biomedical Science (Cancer Biology) Aneuploidy: Using genetic instability to preserve a haploid genome? Submitted by: Ramona Ramdath In partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biomedical Science Examination Committee Signature/Date Major Advisor: David Allison, M.D., Ph.D. Academic James Trempe, Ph.D. Advisory Committee: David Giovanucci, Ph.D. Randall Ruch, Ph.D. Ronald Mellgren, Ph.D. Senior Associate Dean College of Graduate Studies Michael S. Bisesi, Ph.D. Date of Defense: April 10, 2009 Aneuploidy: Using genetic instability to preserve a haploid genome? Ramona Ramdath University of Toledo, Health Science Campus 2009 Dedication I dedicate this dissertation to my grandfather who died of lung cancer two years ago, but who always instilled in us the value and importance of education. And to my mom and sister, both of whom have been pillars of support and stimulating conversations. To my sister, Rehanna, especially- I hope this inspires you to achieve all that you want to in life, academically and otherwise. ii Acknowledgements As we go through these academic journeys, there are so many along the way that make an impact not only on our work, but on our lives as well, and I would like to say a heartfelt thank you to all of those people: My Committee members- Dr. James Trempe, Dr. David Giovanucchi, Dr. Ronald Mellgren and Dr. Randall Ruch for their guidance, suggestions, support and confidence in me. My major advisor- Dr. David Allison, for his constructive criticism and positive reinforcement.
    [Show full text]
  • Methods for Using Small Non-Coding Rnas to Improve Recombinant Protein Expression in Mammalian Cells
    G C A T T A C G G C A T genes Review Methods for Using Small Non-Coding RNAs to Improve Recombinant Protein Expression in Mammalian Cells Sarah Inwood 1,2 ID , Michael J. Betenbaugh 2 and Joseph Shiloach 1,* 1 Biotechnology Core Laboratory, NIDDK, NIH, Bethesda, MD 20892, USA; [email protected] 2 Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD 21218, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-301-496-9719 Received: 17 November 2017; Accepted: 3 January 2018; Published: 9 January 2018 Abstract: The ability to produce recombinant proteins by utilizing different “cell factories” revolutionized the biotherapeutic and pharmaceutical industry. Chinese hamster ovary (CHO) cells are the dominant industrial producer, especially for antibodies. Human embryonic kidney cells (HEK), while not being as widely used as CHO cells, are used where CHO cells are unable to meet the needs for expression, such as growth factors. Therefore, improving recombinant protein expression from mammalian cells is a priority, and continuing effort is being devoted to this topic. Non-coding RNAs are RNA segments that are not translated into a protein and often have a regulatory role. Since their discovery, major progress has been made towards understanding their functions. Non-coding RNA has been investigated extensively in relation to disease, especially cancer, and recently they have also been used as a method for engineering cells to improve their protein expression capability. In this review, we provide information about methods used to identify non-coding RNAs with the potential of improving recombinant protein expression in mammalian cell lines.
    [Show full text]
  • Identification of Gastric Cancer–Related Genes Using a Cdna Microarray Containing Novel Expressed Sequence Tags Expressed in Gastric Cancer Cells
    Vol. 11, 473–482, January 15, 2005 Clinical Cancer Research 473 Identification of Gastric Cancer–Related Genes Using a cDNA Microarray Containing Novel Expressed Sequence Tags Expressed in Gastric Cancer Cells Jeong-Min Kim,1,5 Ho-Yong Sohn,4 overexpressed in z68% of tissues and the MT2A gene Sun Young Yoon,1 Jung-Hwa Oh,1 Jin Ok Yang,1 was down-expressed in 72% of the tissues. Western blotting and immunohistochemical analyses for CDC20 and SKB1 Joo Heon Kim,2 Kyu Sang Song,3 Seung-Moo Rho,2 1 1 5 showed overexpression and localization changes of the Hyan Sook Yoo, Yong Sung Kim, Jong-Guk Kim, corresponding protein in human gastric cancer tissues. 1 and Nam-Soon Kim Conclusions: Novel genes that are related to human 1Genome Research Center, Korea Research Institute of Bioscience and gastric cancer were identified using cDNA microarray Biotechnology; 2Department of Pathology, Eulji University School of 3 developed in our laboratory. In particular, CDC20 and Medicine; and Department of Pathology, College of Medicine, MT2A represent a potential biomarker of human gastric Chungnam National University, Daejeon, Korea; 4Department of Food and Nutrition, Andong National University, Andong, Korea; and cancer. These newly identified genes should provide a 5Department of Microbiology, College of Natural Sciences, Kyungpook valuable resource for understanding the molecular mecha- National University, Daegu, Korea nism associated with tumorigenesis of gastric carcinogenesis and for the discovery of potential diagnostic markers of gastric cancer. ABSTRACT Purpose: Gastric cancer is one of the most frequently INTRODUCTION diagnosed malignancies in the world, especially in Korea and Japan.
    [Show full text]
  • LRF Maintains Genome Integrity by Regulating the Non-Homologous End Joining Pathway of DNA Repair
    ARTICLE Received 17 Dec 2014 | Accepted 11 Aug 2015 | Published 8 Oct 2015 DOI: 10.1038/ncomms9325 OPEN LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair Xue-Song Liu1,*,w, Gurushankar Chandramouly2,w, Emilie Rass2, Yinghua Guan3, Guocan Wang1, Robin M. Hobbs1, Anbazhagan Rajendran2, Anyong Xie2,w, Jagesh V. Shah3, Anthony J. Davis4, Ralph Scully2, Andrea Lunardi1,*,w & Pier Paolo Pandolfi1 Leukemia/lymphoma-related factor (LRF) is a POZ/BTB and Kru¨ppel (POK) transcriptional repressor characterized by context-dependent key roles in cell fate decision and tumorigenesis. Here we demonstrate an unexpected transcription-independent function for LRF in the classical non-homologous end joining (cNHEJ) pathway of double-strand break (DSB) repair. We find that LRF loss in cell lines and mouse tissues results in defective cNHEJ, genomic instability and hypersensitivity to ionizing radiation. Mechanistically, we show that LRF binds and stabilizes DNA-PKcs on DSBs, in turn favouring DNA-PK activity. Importantly, LRF loss restores ionizing radiation sensitivity to p53 null cells, making LRF an attractive biomarker to direct p53-null LRF-deficient tumours towards therapeutic treatments based on genotoxic agents or PARP inhibitors following a synthetic lethal strategy. 1 Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA. 2 Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine, Beth Israel Deaconess Medical Centre, Harvard Medical School, Boston, Massachusetts 02215, USA. 3 Department of Systems Biology, Harvard Medical School, 4 Blackfan Circle, HIM 564, Boston, MA 02115, USA.
    [Show full text]
  • (NF1) As a Breast Cancer Driver
    INVESTIGATION Comparative Oncogenomics Implicates the Neurofibromin 1 Gene (NF1) as a Breast Cancer Driver Marsha D. Wallace,*,† Adam D. Pfefferle,‡,§,1 Lishuang Shen,*,1 Adrian J. McNairn,* Ethan G. Cerami,** Barbara L. Fallon,* Vera D. Rinaldi,* Teresa L. Southard,*,†† Charles M. Perou,‡,§,‡‡ and John C. Schimenti*,†,§§,2 *Department of Biomedical Sciences, †Department of Molecular Biology and Genetics, ††Section of Anatomic Pathology, and §§Center for Vertebrate Genomics, Cornell University, Ithaca, New York 14853, ‡Department of Pathology and Laboratory Medicine, §Lineberger Comprehensive Cancer Center, and ‡‡Department of Genetics, University of North Carolina, Chapel Hill, North Carolina 27514, and **Memorial Sloan-Kettering Cancer Center, New York, New York 10065 ABSTRACT Identifying genomic alterations driving breast cancer is complicated by tumor diversity and genetic heterogeneity. Relevant mouse models are powerful for untangling this problem because such heterogeneity can be controlled. Inbred Chaos3 mice exhibit high levels of genomic instability leading to mammary tumors that have tumor gene expression profiles closely resembling mature human mammary luminal cell signatures. We genomically characterized mammary adenocarcinomas from these mice to identify cancer-causing genomic events that overlap common alterations in human breast cancer. Chaos3 tumors underwent recurrent copy number alterations (CNAs), particularly deletion of the RAS inhibitor Neurofibromin 1 (Nf1) in nearly all cases. These overlap with human CNAs including NF1, which is deleted or mutated in 27.7% of all breast carcinomas. Chaos3 mammary tumor cells exhibit RAS hyperactivation and increased sensitivity to RAS pathway inhibitors. These results indicate that spontaneous NF1 loss can drive breast cancer. This should be informative for treatment of the significant fraction of patients whose tumors bear NF1 mutations.
    [Show full text]
  • An Integrative Genomic Analysis of the Longshanks Selection Experiment for Longer Limbs in Mice
    bioRxiv preprint doi: https://doi.org/10.1101/378711; this version posted August 19, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Title: 2 An integrative genomic analysis of the Longshanks selection experiment for longer limbs in mice 3 Short Title: 4 Genomic response to selection for longer limbs 5 One-sentence summary: 6 Genome sequencing of mice selected for longer limbs reveals that rapid selection response is 7 due to both discrete loci and polygenic adaptation 8 Authors: 9 João P. L. Castro 1,*, Michelle N. Yancoskie 1,*, Marta Marchini 2, Stefanie Belohlavy 3, Marek 10 Kučka 1, William H. Beluch 1, Ronald Naumann 4, Isabella Skuplik 2, John Cobb 2, Nick H. 11 Barton 3, Campbell Rolian2,†, Yingguang Frank Chan 1,† 12 Affiliations: 13 1. Friedrich Miescher Laboratory of the Max Planck Society, Tübingen, Germany 14 2. University of Calgary, Calgary AB, Canada 15 3. IST Austria, Klosterneuburg, Austria 16 4. Max Planck Institute for Cell Biology and Genetics, Dresden, Germany 17 Corresponding author: 18 Campbell Rolian 19 Yingguang Frank Chan 20 * indicates equal contribution 21 † indicates equal contribution 22 Abstract: 23 Evolutionary studies are often limited by missing data that are critical to understanding the 24 history of selection. Selection experiments, which reproduce rapid evolution under controlled 25 conditions, are excellent tools to study how genomes evolve under strong selection. Here we 1 bioRxiv preprint doi: https://doi.org/10.1101/378711; this version posted August 19, 2018.
    [Show full text]
  • Expressed Fusion Gene Landscape and Its Impact in Multiple Myeloma
    Expressed fusion gene landscape and its impact in multiple myeloma The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Cleynen, A., R. Szalat, M. Kemal Samur, S. Robiou du Pont, L. Buisson, E. Boyle, M. L. Chretien, et al. 2017. “Expressed fusion gene landscape and its impact in multiple myeloma.” Nature Communications 8 (1): 1893. doi:10.1038/s41467-017-00638-w. http://dx.doi.org/10.1038/s41467-017-00638-w. Published Version doi:10.1038/s41467-017-00638-w Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:34651902 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA ARTICLE DOI: 10.1038/s41467-017-00638-w OPEN Expressed fusion gene landscape and its impact in multiple myeloma A. Cleynen1, R. Szalat2, M. Kemal Samur2,3, S. Robiou du Pont4, L. Buisson4, E. Boyle4, M.L. Chretien5, K. Anderson2, S. Minvielle 6, P. Moreau6, M. Attal4, G. Parmigiani2,3, J. Corre4, N. Munshi2,7 & H. Avet-Loiseau4 Multiple myeloma is a plasma cell malignancy characterized by recurrent IgH translocations 1234567890 and well described genomic heterogeneity. Although transcriptome profiles in multiple myeloma has been described, landscape of expressed fusion genes and their clinical impact remains unknown. To provide a comprehensive and detailed fusion gene cartography and suggest new mechanisms of tumorigenesis in multiple myeloma, we performed RNA sequencing in a cohort of 255 newly diagnosed and homogeneously treated multiple mye- loma patients with long follow-up.
    [Show full text]
  • Comparative Oncogenomics Implicates the Neurofibromin 1 Gene (NF1) As A
    Genetics: Published Articles Ahead of Print, published on July 30, 2012 as 10.1534/genetics.112.142802 Comparative oncogenomics implicates the Neurofibromin 1 gene (NF1) as a breast cancer driver Marsha D. Wallace1,2, Adam D. Pfefferle3,4 ^, Lishuang Shen1^, Adrian J. McNairn1, Ethan G. Cerami5, Barbara L. Fallon1, Vera D. Rinaldi1, Teresa L. Southard1,6, Charles M. Perou3,4,7, John C. Schimenti1,2,8 1Department of Biomedical Sciences 2Department of Molecular Biology and Genetics 6Section of Anatomic Pathology 8Center for Vertebrate Genomics Cornell University, Ithaca, NY 14853 3Department of Pathology and Laboratory Medicine 4Lineberger Comprehensive Cancer Center 7Department of Genetics University of North Carolina, Chapel Hill, NC 27514 5Memorial Sloan-Kettering Cancer Center, New York, NY 10065 1 Copyright 2012. ^ Contributed equally to this paper Running Title: NF1 deletion in breast cancer Key Words: breast cancer; mouse genetics; neurofibromin; NF1; genomic instability. Corresponding author: John Schimenti, Ph.D. Cornell Univ. College of Veterinary Medicine Ithaca, NY 14850 email: [email protected] phone 607-253-3636 Fax 607-253-3789 2 ABSTRACT Identifying genomic alterations driving breast cancer is complicated by tumor diversity and genetic heterogeneity. Relevant mouse models are powerful for untangling this problem because such heterogeneity can be controlled. Inbred Chaos3 mice exhibit high levels of genomic instability leading to mammary tumors that have tumor gene expression profiles closely resembling mature human mammary luminal cell signatures. We genomically characterized mammary adenocarcinomas from these mice to identify cancer-causing genomic events that overlap common alterations in human breast cancer. Chaos3 tumors underwent recurrent copy number alterations (CNAs), particularly deletion of the RAS inhibitor Neurofibromin 1 (Nf1) in nearly all cases.
    [Show full text]
  • Structure and Sequence of the Sex Determining Locus in Two Wild Populations of Nile Tilapia
    G C A T T A C G G C A T genes Article Structure and Sequence of the Sex Determining Locus in Two Wild Populations of Nile Tilapia Cécile Triay 1,2, Matthew A. Conte 3, Jean-François Baroiller 1,2, Etienne Bezault 4 , Frances E. Clark 3 , David J. Penman 5, Thomas D. Kocher 3 and Helena D’Cotta 1,2,* 1 UMR-Institut des Sciences de l’Evolution de Montpellier, Centre National de la Recherche Scientifique, Institut de Recherche pour le Développement, Ecole Pratique des Hautes Etudes, University of Montpellier, 34090 Montpellier, France; [email protected] (C.T.); [email protected] (J.-F.B.) 2 UMR-Institut des Sciences de l’Evolution de Montpellier, Centre de Coopération Internationale en Recherche Agronomique pour le Développement, Campus Int. Baillarguet, 34398 Montpellier, France 3 Department of Biology, University of Maryland, College Park, MD 20742, USA; [email protected] (M.A.C.); [email protected] (F.E.C.); [email protected] (T.D.K.) 4 UMR BOREA, CNRS-7208/MNHN/UPMC/IRD-207/UCN/UA, Université des Antilles, 97159 Guadeloupe, France; [email protected] 5 Institute of Aquaculture, School of Natural Sciences, University of Stirling, Stirling, Scotland FK9 4LA, UK; [email protected] * Correspondence: [email protected]; Tel.: +33-4-67593994 Received: 17 July 2020; Accepted: 27 August 2020; Published: 29 August 2020 Abstract: In domesticated strains of the Nile tilapia, phenotypic sex has been linked to genetic variants on linkage groups 1, 20 and 23. This diversity of sex-loci might reflect a naturally polymorphic sex determination system in Nile tilapia, or it might be an artefact arising from the process of domestication.
    [Show full text]
  • Structure-Function Relationships of Rna and Protein in Synaptic Plasticity
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2017 Structure-Function Relationships Of Rna And Protein In Synaptic Plasticity Sarah Middleton University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Bioinformatics Commons, Biology Commons, and the Neuroscience and Neurobiology Commons Recommended Citation Middleton, Sarah, "Structure-Function Relationships Of Rna And Protein In Synaptic Plasticity" (2017). Publicly Accessible Penn Dissertations. 2474. https://repository.upenn.edu/edissertations/2474 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/2474 For more information, please contact [email protected]. Structure-Function Relationships Of Rna And Protein In Synaptic Plasticity Abstract Structure is widely acknowledged to be important for the function of ribonucleic acids (RNAs) and proteins. However, due to the relative accessibility of sequence information compared to structure information, most large genomics studies currently use only sequence-based annotation tools to analyze the function of expressed molecules. In this thesis, I introduce two novel computational methods for genome-scale structure-function analysis and demonstrate their application to identifying RNA and protein structures involved in synaptic plasticity and potentiation—important neuronal processes that are thought to form the basis of learning and memory. First, I describe a new method for de novo identification of RNA secondary structure motifs enriched in co-regulated transcripts. I show that this method can accurately identify secondary structure motifs that recur across three or more transcripts in the input set with an average recall of 0.80 and precision of 0.98. Second, I describe a tool for predicting protein structural fold from amino acid sequence, which achieves greater than 96% accuracy on benchmarks and can be used to predict protein function and identify new structural folds.
    [Show full text]
  • Finding Fusion Genes Resulting from Chromosome Rearrangement by Analyzing the Expressed Sequence Databases
    Finding fusion genes resulting from chromosome rearrangement by analyzing the expressed sequence databases Yoonsoo Hahn*, Tapan Kumar Bera*, Kristen Gehlhaus†, Ilan R. Kirsch†, Ira H. Pastan*, and Byungkook Lee*‡ *Laboratory of Molecular Biology and †Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 Contributed by Ira H. Pastan, July 28, 2004 Chromosomal rearrangements resulting in gene fusions are fre- Materials and Methods quently involved in carcinogenesis. Here, we describe a semiauto- Data Sets. We used the publicly available mRNA- and EST-to- matic procedure for identifying fusion gene transcripts by using genome alignment data (‘‘all࿝mrna,’’ 141,300 alignments from publicly available mRNA and EST databases. With this procedure, 128,007 mRNAs, and ‘‘all࿝est,’’ 4,957,003 alignments from we have identified 96 transcript sequences that are derived from 4,642,477 ESTs) from the University of California, Santa Cruz 60 known fusion genes. Also, 47 or more additional sequences Human Genome Browser database (http:͞͞genome.ucsc.edu; appear to be derived from 20 or more previously unknown puta- October 27, 2003, release, Version hg16). These alignments were tive fusion genes. We have experimentally verified the presence of produced by BLAT by using mRNA and EST databases that were ͞ a previously unknown IRA1 RGS17 fusion in the breast cancer cell filtered to remove vector sequences and the human genome line MCF7. The fusion gene encodes the full-length RGS17 protein, assembly National Center for Biotechnology Information Build a regulator of G protein-coupled signaling, under the control of the 34, July 2003 freeze.
    [Show full text]